The Decline of the Experimental Paradigm During the COVID-19 Pandemic: A Template for the Future

Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/(online access: 16/08/2020)

Blocking information on COVID-19 can fuel the spread of misinformation.

Nature. 2020; 580 (): 306

The online competition between pro- and anti-vaccination views.

Nature. 2020;

Scientists are drowning in COVID-19 papers. Can new tools keep them afloat?.

Science. 2020;

• White R.G.
• Hakim A.J.
• Salganik M.J.
• Spiller M.W.
• Johnston L.G.
• Kerr L.
• Kendall C.
• Drake A.
• Wilson D.
• Orroth K.
• Egger M.
• Hladik W.

Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement.

J Clin Epidemiol. 2015;

• Sharma M.
• Scarr S.
• Kelland K.

Speed Science: The risks of swiftly spreading coronavirus research.

Reuters. 2020;

• Trogen B.
• Oshinsky D.
• Caplan A.

Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.

Jama. 2020;

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.

Lancet. 2001; 357: 373-380

Which clinical studies provide the best evidence? The best RCT still trumps the best observational study.

Bmj. 2000; 321: 255-256

• Rush C.J.
• Campbell R.T.
• Jhund P.S.
• Petrie M.C.
• McMurray J.J.V.

Association is not causation: treatment effects cannot be estimated from observational data in heart failure.

Eur Heart J. 2018; 39: 3417-3438

Small studies: strengths and limitations.

in: Eur Respir J. 32. 2008: 1141-1143 ()

• Wang M.T.
• Bolland M.J.
• Gamble G.
• Grey A.

Media Coverage, Journal Press Releases and Editorials Associated with Randomized and Observational Studies in High-Impact Medical Journals: A Cohort Study.

PLoS One. 2015; 10e0145294

• Guertin J.R.
• Rahme E.
• Dormuth C.R.
• LeLorier J.

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods.

BMC Med Res Methodol. 2016; 16: 22

The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.

Stat Med. 2007; 26: 20-36

• Kaplan R.M.
• Chambers D.A.
• Glasgow R.E.

Big data and large sample size: a cautionary note on the potential for bias.

Clin Transl Sci. 2014; 7: 342-346

• Freemantle N.
• Marston L.
• Walters K.
• Wood J.
• Reynolds M.R.
• Petersen I.

Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research.

Bmj. 2013; 347: f6409

Bias and causal associations in observational research.

Lancet. 2002; 359: 248-252

Discussing hidden bias in observational studies.

Ann Intern Med. 1991; 115: 901-905

• Dickerman B.A.
• García-Albéniz X.
• Logan R.W.
• Denaxas S.
• Hernán M.A.

Avoidable flaws in observational analyses: an application to statins and cancer.

Nat Med. 2019; 25: 1601-1606

Win-Win: Reconciling Social Epidemiology and Causal Inference.

Am J Epidemiol. 2020; 189: 167-170

• Blagoev K.B.
• Wilkerson J.
• Fojo T.

Hazard ratios in cancer clinical trials–a primer.

Nat Rev Clin Oncol. 2012; 9 (): 178-183

• Geleris J.
• Sun Y.
• Platt J.
• Zucker J.
• Baldwin M.
• Hripcsak G.
• Labella A.
• Manson D.
• Kubin C.
• Barr R.G.
• Sobieszczyk M.E.
• Schluger N.W.

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.

N Engl J Med. 2020;

• Mehra M.R.
• Desai S.S.
• Kuy S.
• Henry T.D.
• Patel A.N.

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.

N Engl J Med. 2020;

• Shang L.
• Zhao J.
• Hu Y.
• Du R.
• Cao B.

On the use of corticosteroids for 2019-nCoV pneumonia.

Lancet. 2020; 395: 683-684

• Richardson P.
• Griffin I.
• Tucker C.
• Smith D.
• Oechsle O.
• Phelan A.
• Stebbing J.

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.

Lancet. 2020; 395: e30-e31

• Rosenberg E.S.
• Dufort E.M.
• Udo T.
• Wilberschied L.A.
• Kumar J.
• Tesoriero J.
• Weinberg P.
• Kirkwood J.
• Muse A.
• DeHovitz J.
• Blog D.S.
• Hutton B.
• Holtgrave D.R.
• Zucker H.A.

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.

Jama. 2020;

• Shen C.
• Wang Z.
• Zhao F.
• Yang Y.
• Li J.
• Yuan J.
• Wang F.
• Li D.
• Yang M.
• Xing L.
• Wei J.
• Xiao H.
• Qu J.
• Qing L.
• Chen L.
• Xu Z.
• Peng L.
• Li Y.
• Zheng H.
• Chen F.
• Huang K.
• Jiang Y.
• Liu D.
• Zhang Z.
• Liu Y.
• Liu L.

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

Jama. 2020;

• Elharrar X.
• Trigui Y.
• Dols A.M.
• Touchon F.
• Martinez S.
• Prud’homme E.
• Papazian L.

Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure.

Jama. 2020;

• Grein J.
• Ohmagari N.
• Shin D.
• Diaz G.
• Asperges E.
• Castagna A.
• Feldt T.
• Green G.
• Green M.L.
• Lescure F.X.
• Nicastri E.
• Oda R.
• Yo K.
• Quiros-Roldan E.
• Studemeister A.
• Redinski J.
• Ahmed S.
• Bernett J.
• Chelliah D.
• Chen D.
• Chihara S.
• Cohen S.H.
• Cunningham J.
• D’Arminio Monforte 0.
• Ismail S.
• Kato H.
• Lapadula G.
• L’Her E.
• Maeno T.
• Majumder S.
• Massari M.
• Mora-Rillo M.
• Mutoh Y.
• Nguyen D.
• Verweij E.
• Zoufaly A.
• Osinusi A.O.
• DeZure A.
• Zhao Y.
• Zhong L.
• Chokkalingam A.
• Elboudwarej E.
• Telep L.
• Timbs L.
• Henne I.
• Sellers S.
• Cao H.
• Tan S.K.
• Winterbourne L.
• Desai P.
• Mera R.
• Gaggar A.
• Myers R.P.
• Brainard D.M.
• Childs R.
• Flanigan T.

Compassionate Use of Remdesivir for Patients with Severe Covid-19.

N Engl J Med. 2020;

• Sartini C.
• Tresoldi M.
• Scarpellini P.
• Tettamanti A.
• Carcò F.
• Landoni G.
• Zangrillo A.

Respiratory Parameters in Patients With COVID-19 After Using Noninvasive Ventilation in the Prone Position Outside the Intensive Care Unit.

Jama. 2020;

• de Abajo F.J.
• Rodríguez-Martín S.
• Lerma V.
• Mejía-Abril G.
• Aguilar M.
• García-Luque A.
• Laredo L.
• Laosa O.
• Centeno-Soto G.A.
• Ángeles Gálvez M.
• Puerro M.
• González-Rojano E.
• Pedraza L.
• de Pablo I.
• Abad-Santos F.
• Rodríguez-Mañas L.
• Gil M.
• Tobías A.
• Rodríguez-Miguel A.
• Rodríguez-Puyol D.

Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.

Lancet. 2020;

• Mehra M.
• Desai S.
• Ruschitzka F.
• Patel A.

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.

Lancet. 2020;

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.

Lancet. 2020;

• Thomas L.E.
• Bonow R.O.
• Pencina M.J.

Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).

JAMA Cardiol. 2020;

• Fosbøl E.L.
• Butt J.H.
• Østergaard L.
• Andersson C.
• Selmer C.
• Kragholm K.
• Schou M.
• Phelps M.
• Gislason G.H.
• Gerds T.A.
• Torp-Pedersen C.
• Køber L.

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.

Jama. 2020; 324: 168-177

• Cao B.
• Wang Y.
• Wen D.
• Liu W.
• Wang J.
• Fan G.
• Ruan L.
• Song B.
• Cai Y.
• Wei M.
• Li X.
• Xia J.
• Chen N.
• Xiang J.
• Yu T.
• Bai T.
• Xie X.
• Zhang L.
• Li C.
• Yuan Y.
• Chen H.
• Li H.
• Huang H.
• Tu S.
• Gong F.
• Liu Y.
• Wei Y.
• Dong C.
• Zhou F.
• Gu X.
• Xu J.
• Liu Z.
• Zhang Y.
• Shang L.
• Wang K.
• Li K.
• Zhou X.
• Dong X.
• Qu Z.
• Lu S.
• Hu X.
• Ruan S.
• Luo S.
• Wu J.
• Peng L.
• Cheng F.
• Pan L.
• Zou J.
• Jia C.
• Liu X.
• Wang S.
• Wu X.
• Ge Q.
• He J.
• Zhan H.
• Qiu F.
• Guo L.
• Huang C.
• Jaki T.
• Hayden F.G.
• Horby P.W.
• Zhang D.
• Wang C.

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

N Engl J Med. 2020; 382: 1787-1799

• Hung I.F.
• Lung K.C.
• Tso E.Y.
• Liu R.
• Chung T.W.
• Chu M.Y.
• Ng Y.Y.
• Lo J.
• Chan J.
• Tam A.R.
• Shum H.P.
• Chan V.
• Wu A.K.
• Sin K.M.
• Leung W.S.
• Law W.L.
• Lung D.C.
• Sin S.
• Yeung P.
• Yip C.C.
• Zhang R.R.
• Fung A.Y.
• Yan E.Y.
• Leung K.H.
• Ip J.D.
• Chu A.W.
• Chan W.M.
• Ng A.C.
• Lee R.
• Fung K.
• Yeung A.
• Wu T.C.
• Chan J.W.
• Yan W.W.
• Chan J.F.
• Lie A.K.
• Tsang O.T.
• Cheng V.C.
• Que T.L.
• Lau C.S.
• Chan K.H.
• To K.K.
• Yuen K.Y.

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.

Lancet. 2020;

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.

Lancet. May 16, 2020; 395: 1569-1578

Remdesivir for the Treatment of Covid-19 — Preliminary Report.

NEJM. 2020;

• Goldman J.D.
• Lye D.C.B.
• Hui D.S.
• Marks K.M.
• Bruno R.
• Montejano R.
• Spinner C.D.
• Galli M.
• Ahn M.Y.
• Nahass R.G.
• Chen Y.S.
• SenGupta D.
• Hyland R.H.
• Osinusi A.O.
• Cao H.
• Blair C.
• Wei X.
• Gaggar A.
• Brainard D.M.
• Towner W.J.
• Muñoz J.
• Mullane K.M.
• Marty F.M.
• Tashima K.T.
• Diaz G.
• Subramanian A.

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.

N Engl J Med. 2020;

• Boulware D.R.
• Pullen M.F.
• Bangdiwala A.S.
• Pastick K.A.
• Lofgren S.M.
• Okafor E.C.
• Skipper C.P.
• Nascene A.A.
• Nicol M.R.
• Abassi M.
• Engen N.W.
• Cheng M.P.
• LaBar D.
• Lother S.A.
• MacKenzie L.J.
• Drobot G.
• Marten N.
• Zarychanski R.
• Kelly L.E.
• Schwartz I.S.
• McDonald E.G.
• Rajasingham R.
• Lee T.C.
• Hullsiek K.H.

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

N Engl J Med. 2020;

• Li L.
• Zhang W.
• Hu Y.
• Tong X.
• Zheng S.
• Yang J.
• Kong Y.
• Ren L.
• Wei Q.
• Mei H.
• Hu C.
• Tao C.
• Yang R.
• Wang J.
• Yu Y.
• Guo Y.
• Wu X.
• Xu Z.
• Zeng L.
• Xiong N.
• Chen L.
• Man N.
• Liu Y.
• Xu H.
• Deng E.
• Zhang X.
• Li C.
• Wang C.
• Su S.
• Zhang L.
• Wu Y.
• Liu Z.

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.

Jama. 2020;

• Horby P.
• Lim W.S.
• Emberson J.R.
• Mafham M.
• Bell J.L.
• Linsell L.
• Staplin N.
• Brightling C.
• Ustianowski A.
• Elmahi E.
• Prudon B.
• Green C.
• Felton T.
• Chadwick D.
• Rege K.
• Fegan C.
• Chappell L.C.
• Faust S.N.
• Jaki T.
• Jeffery K.
• Montgomery A.
• Rowan K.
• Juszczak E.
• Baillie J.K.
• Haynes R.
• Landray M.J.

Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report.

N Engl J Med. 2020;

signatories, J. W. o. t. b. o., An open letter to Mehra et al and The Lancet. 2020.

• Hernandez A.V.
• Roman Y.M.
• Pasupuleti V.
• Barboza J.J.
• White C.M.

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.

Ann Intern Med. 2020;

• Alexander P.E.
• Debono V.B.
• Mammen M.J.
• Iorio A.
• Aryal K.
• Deng D.
• Brocard E.
• Alhazzani W.

COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine.

J Clin Epidemiol. 2020;

• North C.M.
• Dougan M.L.
• Sacks C.A.

Improving Clinical Trial Enrollment – In the Covid-19 Era and Beyond.

N Engl J Med. 2020;

Research in the Context of a Pandemic.

N Engl J Med. 2020;

An organizational analysis of the World Health Organization: narrowing the gap between promise and performance.

Soc Sci Med. 1995; 40: 731-742

• Bloom B.R.
• Farmer P.E.
• Rubin E.J.

WHO’s Next – The United States and the World Health Organization.

N Engl J Med. 2020;

• Devaux C.A.
• Rolain J.M.
• Colson P.
• Raoult D.

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?.

Int J Antimicrob Agents. 2020; 105938

Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #3. https://www.ema.europa.eu/en/news/global-regulators-work-towards-alignment-policy-approaches-regulatory-flexibility-during-covid-19-2(online access: 16/08/2020).

• Armstrong P.W.
• Naylor C.D.

Counteracting Health Misinformation: A Role for Medical Journals?.

Jama. 2019; 321: 1863-1864

• Chou W.S.
• Oh A.
• Klein W.M.P.

Addressing Health-Related Misinformation on Social Media.

Jama. 2018; 320: 2417-2418

Protecting the Value of Medical Science in the Age of Social Media and “Fake News”.

Jama. 2018; 320: 2415-2416

• Vosoughi S.
• Roy D.
• Aral S.

The spread of true and false news online.

Science. 2018; 359: 1146-1151

In India, Hindu pride boosts pseudoscience.

Science. 2019; 363 (): 679-680

• Broniatowski D.A.
• Jamison A.M.
• Qi S.
• AlKulaib L.
• Chen T.
• Benton A.
• Quinn S.C.
• Dredze M.

Weaponized Health Communication: Twitter Bots and Russian Trolls Amplify the Vaccine Debate.

Am J Public Health. 2018; 108: 1378-1384

Medical Education in the Era of Alternative Facts.

N Engl J Med. 2017; 377: 607-609

Infographic: The Best And Worst Science News Sites.

American Council on Science and Health. 2017;

Roth, Y.; Achuthan, A., Building rules in public: Our approach to synthetic & manipulated media. https://blog.twitter.com/en_us/topics/company/2020/new-approach-to-synthetic-and-manipulated-media.html(online access: 16/08/2020).

• Fast S.M.
• Kim L.
• Cohn E.L.
• Mekaru S.R.
• Brownstein J.S.
• Markuzon N.

Predicting social response to infectious disease outbreaks from internet-based news streams.

Ann Oper Res. 2018; 263 : 551-564

• Hill J.A.
• Agewall S.
• Baranchuk A.
• Booz G.W.
• Borer J.S.
• Camici P.G.
• Chen P.S.
• Dominiczak A.F.
• Erol C.
• Grines C.L.
• Gropler R.
• Guzik T.J.
• Heinemann M.K.
• Iskandrian A.E.
• Knight B.P.
• London B.
• Luscher T.F.
• Metra M.
• Musunuru K.
• Nallamothu B.K.
• Natale A.
• Saksena S.
• Picard M.H.
• Rao S.V.
• Remme W.J.
• Rosenson R.S.
• Sweitzer N.K.
• Timmis A.
• Vrints C.

Medical Misinformation: Vet the Message!.

Eur Heart J. 2019; 40: 404-405

• Atkins D.
• Best D.
• Briss P.A.
• Eccles M.
• Falck-Ytter Y.
• Flottorp S.
• Guyatt G.H.
• Harbour R.T.
• Haugh M.C.
• Henry D.
• Hill S.
• Jaeschke R.
• Leng G.
• Liberati A.
• Magrini N.
• Mason J.
• Middleton P.
• Mrukowicz J.
• O’Connell D.
• Oxman A.D.
• Phillips B.
• Schünemann H.J.
• Edejer T.
• Varonen H.
• Vist G.E.
• Williams Jr., J.W.
• Zaza S.

Grading quality of evidence and strength of recommendations.

Bmj. 2004; 328: 1490

• Ladeiras-Lopes R.
• Clarke S.
• Vidal-Perez R.
• Alexander M.
• Luscher T.F.

Twitter promotion predicts citation rates of cardiovascular articles: a preliminary analysis from the ESC Journals Randomized Study.

Eur Heart J. 2020;

• Thamman R.
• Gulati M.
• Narang A.
• Utengen A.
• Mamas M.A.
• Bhatt D.L.

Twitter-based learning for continuing medical education?.

Eur Heart J. 2020;

Nudge: Improving Decisions about Health, Wealth, and Happiness.

2008

• van Eck N.J.
• Waltman L.
• van Raan A.F.
• Klautz R.J.
• Peul W.C.

Citation analysis may severely underestimate the impact of clinical research as compared to basic research.

PLoS One. 2013; 8: e62395

Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus. https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-interim-phase-1-data-its-mrna-vaccine/(online access: 16/08/2020).

In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead. https://www.nytimes.com/2020/04/27/world/europe/coronavirus-vaccine-update-oxford.html(online access: 16/08/2020).

Haseltine, W.Rush to share good news on COVID-19 drugs is undermining science. https://www.washingtonpost.com/opinions/2020/05/19/rush-share-good-news-covid-19-drugs-is-undermining-science/(online access: 16/08/2020).